on May 12, 2022 Acutus Medical, Inc. announced that Vince Burgess was departing from his position as President and CEO of the Company, as well as a member of the Company's board of directors, under mutually agreeable terms, effective May 13, 2022. The company also disclosed that David Roman, the Company's chief financial officer, will act as the Company's interim chief executive officer, effective May 13, 2022, while maintaining
his duties as the Company's chief financial officer.
Acutus Medical, Inc. is focused on the production of left-heart access products under its distribution agreement with Medtronic, Inc. (Medtronic). The Company is solely focused on supporting the manufacturing and distribution of products to Medtronic. It manufactures transseptal crossing devices and associated accessories, such as integrated transseptal dilators and needles, fixed-curve or steerable introducers, and steerable sheaths (Products). These Products are used to access the left side, or left atrium, of the cardiac anatomy and are used in a range of medical applications, including in electrophysiology and structural heart procedures. The technology supports physicians during a critical component of an ablation or structural heart procedure. The transseptal crossing devices that it manufactures for Medtronic include versions that are length-, diameter- and tip-matched and designed to lock into the hub of sheaths used in many left-heart procedures.
ACUTUS MEDICAL, INC. 
